Favipiravir for COVID-19 in a Patient on Hemodialysis

被引:6
|
作者
Hirai, Daisuke [1 ]
Yamashita, Daisuke [1 ,2 ]
Seta, Koichi [2 ]
机构
[1] Natl Hosp Org Kyoto Med Ctr, Dept Nephrol, Kyoto, Japan
[2] Natl Hosp Org Kyoto Med Ctr, Dept Pharm, Kyoto, Japan
关键词
D O I
10.1053/j.ajkd.2020.09.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:153 / 154
页数:3
相关论文
共 50 条
  • [31] COVID-19 Infection in a Patient with Common Variable Immunodeficiency: Experience with Favipiravir and Intravenous Immunoglobulin
    Emre, Emre
    Tazegul, Gokhan
    [J]. ASTHMA ALLERGY IMMUNOLOGY, 2021, 19 (02): : 118 - 121
  • [32] Fluorescence of ocular surface in a Covid-19 patient after Favipiravir treatment: a case report
    Doran, Mehmet Ali
    Aytogan, Hasan
    Ayintap, Emre
    [J]. VIROLOGY JOURNAL, 2021, 18 (01)
  • [33] The first case of COVID-19 pneumonia in a hemodialysis patient in Japan
    Kuroki, Yusuke
    Hiyama, Kazutoshi
    Minami, Junya
    Takeuchi, Miyoshi
    Shojima, Masumi
    Matsueda, Shumei
    Nagae, Hiroshi
    Nakano, Toshiaki
    [J]. CEN CASE REPORTS, 2020, 9 (04) : 404 - 408
  • [34] The first case of COVID-19 pneumonia in a hemodialysis patient in Japan
    Yusuke Kuroki
    Kazutoshi Hiyama
    Junya Minami
    Miyoshi Takeuchi
    Masumi Shojima
    Shumei Matsueda
    Hiroshi Nagae
    Toshiaki Nakano
    [J]. CEN Case Reports, 2020, 9 : 404 - 408
  • [35] Effectiveness of favipiravir in COVID-19: a live systematic review
    Ozlusen, Batu
    Kozan, Sima
    Akcan, Rustu Emre
    Kalender, Mekselina
    Yaprak, Dogukan
    Peltek, Ibrahim Batuhan
    Keske, Siran
    Gonen, Mehmet
    Ergonul, Onder
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (12) : 2575 - 2583
  • [36] Effectiveness of favipiravir in COVID-19: a live systematic review
    Batu Özlüşen
    Şima Kozan
    Rüştü Emre Akcan
    Mekselina Kalender
    Doğukan Yaprak
    İbrahim Batuhan Peltek
    Şiran Keske
    Mehmet Gönen
    Önder Ergönül
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 2575 - 2583
  • [37] Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID-19
    Irie, Kei
    Nakagawa, Atsushi
    Fujita, Hirotoshi
    Tamura, Ryo
    Eto, Masaaki
    Ikesue, Hiroaki
    Muroi, Nobuyuki
    Tomii, Keisuke
    Hashida, Tohru
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (05): : 880 - 885
  • [38] Favipiravir and its potentials in COVID-19 pandemic: An update
    Dao Ngoc Hien Tam
    Qarawi, Ahmad T.
    Mai Ngoc Luu
    Turnage, Morgan
    Linh Tran
    Tawfik, Gehad Mohamed
    Le Huu Nhat Minh
    Nguyen Tien Huy
    Iiyama, Tatsuo
    Kita, Kyoshi
    Hirayama, Kenji
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2021, 14 (10) : 433 - 439
  • [39] PIONEER trial: favipiravir to treat moderate COVID-19
    Shalhoub, Sarah
    [J]. LANCET RESPIRATORY MEDICINE, 2023, 11 (05): : 392 - 393
  • [40] Favipiravir exposure and pregnancy outcome of COVID-19 patients
    Tirmikcioglu, Zeynep
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 268 : 110 - 115